The 2016 revision of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines provides updated recommendations for the treatment of allergic rhinitis. The revision addresses six key questions, focusing on the relative merits of oral H1-antihistamines, intranasal H1-antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists, either alone or in combination. The guidelines aim to improve patients' quality of life, school and work productivity by providing clear and evidence-based advice for clinicians and patients. The recommendations are based on systematic reviews of health effects, patient values and preferences, and resource requirements, following the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. The guidelines emphasize the importance of considering individual patient values, preferences, and specific considerations when choosing the most appropriate treatment.The 2016 revision of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines provides updated recommendations for the treatment of allergic rhinitis. The revision addresses six key questions, focusing on the relative merits of oral H1-antihistamines, intranasal H1-antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists, either alone or in combination. The guidelines aim to improve patients' quality of life, school and work productivity by providing clear and evidence-based advice for clinicians and patients. The recommendations are based on systematic reviews of health effects, patient values and preferences, and resource requirements, following the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. The guidelines emphasize the importance of considering individual patient values, preferences, and specific considerations when choosing the most appropriate treatment.